Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novartis identifies thrombin inhibitors with improved pharmacodynamic and pharmacokinetic properties

April 7, 1999

Ibex implements major changes in new phase III study of Neutralase

April 6, 1999

New anticoagulants/antithrombotics revealed by Zeneca

April 6, 1999

Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model

April 1, 1999

Aspirin should not interfere with the cardioprotective activity of terbogrel

March 31, 1999

NovoSeven approved in the U.S.

March 30, 1999

Pharmacokinetics and safety of lotrafiban assessed in phase II trial

March 26, 1999

Nonbenzamidine factor Xa inhibitors in the pipeline at Rhone-Poulenc Rorer

March 25, 1999

Suntory presents SUN-C5174, a 5-HT2 antagonist with potent antiplatelet activity

March 25, 1999

Novel thrombin inhibitor series from 3-D discussed at ACS meeting

March 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...